REGN Competitors & Alternatives
Compare Regeneron Pharmaceuticals Inc with similar stocks in the same industry
Biotechnology
REGN
Main Stock$923.34
-2.35%
Tradestie Score
42
Market Cap
$63.59B
P/E Ratio
20.9
Revenue Growth
36.3%
Analyst Upside
+7.3%
Supply-Chain & Ecosystem Map (Customers, Suppliers & Direct Competitors)
Bottleneck Score: 5/10
Drug Discovery Biotech
Drug Design
Top Competitors
215 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
AMGN
Amgen Inc
|
$438.82
-1.14%
|
$160.70B | 25.7 | 43 | Compare |
|
GILD
Gilead Sciences Inc
|
$166.53
-1.45%
|
$137.92B | - | 47 | Compare |
|
VRTX
Vertex Pharmaceuticals Inc
|
$520.66
-2.94%
|
$103.64B | 34.5 | 47 | Compare |
|
ALNY
Alnylam Pharmaceuticals, Inc.
|
$147.82
-1.06%
|
$60.38B | 7.5 | 46 | Compare |
|
ARGX
argenx SE American Depositary Shares
|
$942.04
+0.08%
|
$46.96B | 32.8 | 43 | Compare |
|
ONC
BeOne Medicines Ltd. American Depositary Shares
|
$399.70
-0.97%
|
$36.81B | 51.7 | 43 | Compare |
|
INSM
Insmed, Inc.
|
$144.46
+20.58%
|
$31.13B | - | 34 | Compare |
|
BNTX
BioNTech SE American Depositary Share
|
$81.38
-2.26%
|
$24.57B | - | 49 | Compare |
|
BIIB
Biogen Inc. Common Stock
|
$247.13
-1.70%
|
$22.61B | 108.8 | 50 | Compare |
|
GMAB
Genmab A/S ADS
|
$51.35
+0.75%
|
$19.56B | 43.6 | 43 | Compare |
More REGN Analysis
Data updated: Nov 20, 2026 | Industry: Biotechnology (SIC 2834)
215 stocks in this industry